Agnes Farkas

Dr. Agnes Farkas

University of Pécs, Faculty of Pharmacy, Department of Pharmacognosy
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2012 in Genetic Resources and Crop Evolution
Verified
Journal Article
Closed access
PDF file
NPNora Papp
Nora Papp
KBKata Birkás-Frendl
Kata Birkás-Frendl
Agnes FarkasAgnes Farkas
Agnes Farkas
Andrea PieroniAndrea Pieroni
Andrea Pieroni

1 April 2012 in Journal of Chromatography A
Verified
Journal Article
Closed access
SJSilvia Jakabová
Silvia Jakabová
LVLajos Vincze
Lajos Vincze
Agnes FarkasAgnes Farkas
Agnes Farkas
FKFerenc Kilár
Ferenc Kilár
BBBorbála Boros
Borbála Boros
AFAttila Felinger
Attila Felinger

25 November 2021 in Molecules
Verified
Journal Article
Open access
PDF file
ECEszter Csikós
Eszter Csikós
AHAdrienn Horváth
Adrienn Horváth
KÁKamilla Ács
Kamilla Ács
NPNora Papp
Nora Papp
VBViktoria Lilla Balazs
Viktoria Lilla Balazs
YZYueping Zhang
Yueping Zhang
Benign prostatic hyperplasia (BPH) is one of the most common urinary diseases affecting men, generally after the age of 50. The prevalence of this multifactorial disease increases with age. With aging, the plasma level of testosterone decreases, as well as the testosterone/estrogen ratio, resulting in increased estrogen activity, which may facilitate the hyperplasia of the prostate cells. Another theory focuses on dihydrotestosterone (DHT) and the activity of the enzyme 5α-reductase, which converts testosterone to DHT. In older men, the activity of this enzyme increases, leading to a decreased testosterone/DHT ratio. DHT may promote prostate cell growth, resulting in hyperplasia. Some medicinal plants and their compounds act by modulating this enzyme, and have the above-mentioned targets. This review focuses on herbal drugs that are most widely used in the treatment of BPH, including pumpkin seed, willow herb, tomato, maritime pine bark, Pygeum africanum bark, rye pollen, saw palmetto fruit, and nettle root, highlighting the latest results of preclinical and clinical studies, as well as safety issues. In addition, the pharmaceutical care and other therapeutic options of BPH, including pharmacotherapy and surgical options, are discussed, summarizing and comparing the advantages and disadvantages of each therapy.

1 January 2007 in The Plant Cell
Verified
Journal Article
Closed access
SSSue Sherman-Broyles
Sue Sherman-Broyles
NBNathan Boggs
Nathan Boggs
Agnes FarkasAgnes Farkas
Agnes Farkas
PLPei Liu
Pei Liu
JVJulia Vrebalov
Julia Vrebalov
JNJune B. Nasrallah
June B. Nasrallah
Loss of self-incompatibility (SI) in Arabidopsis thaliana was accompanied by inactivation of genes required for SI, including S-LOCUS RECEPTOR KINASE (SRK) and S-LOCUS CYSTEINE-RICH PROTEIN (SCR), coadapted genes that constitute the SI specificity-determining S haplotype. Arabidopsis accessions are polymorphic for ΨSRK and ΨSCR, but it is unknown if the species harbors structurally different S haplotypes, either representing relics of ancestral functional and structurally heteromorphic S haplotypes or resulting from decay concomitant with or subsequent to the switch to self-fertility. We cloned and sequenced the S haplotype from C24, in which self-fertility is due solely to S locus inactivation, and show that this haplotype was produced by interhaplotypic recombination. The highly divergent organization and sequence of the C24 and Columbia-0 (Col-0) S haplotypes demonstrate that the A. thaliana S locus underwent extensive structural remodeling in conjunction with a relaxation of selective pressures that once preserved the integrity and linkage of coadapted SRK and SCR alleles. Additional evidence for this process was obtained by assaying 70 accessions for the presence of C24- or Col-0–specific sequences. Furthermore, analysis of SRK and SCR polymorphisms in these accessions argues against the occurrence of a selective sweep of a particular allele of SCR, as previously proposed.

3 April 2010 in Chromatographia
Verified
Journal Article
Closed access
PDF file
BBBorbála Boros
Borbála Boros
Agnes FarkasAgnes Farkas
Agnes Farkas
SJSilvia Jakabová
Silvia Jakabová
IBIvett Bacskay
Ivett Bacskay
FKFerenc Kilár
Ferenc Kilár
AFAttila Felinger
Attila Felinger

10 May 2021 in Molecules
Verified
Journal Article
Open access
PDF file
ABAlexandra Bodo
Alexandra Bodo
LNLilla Nagy-Radványi
Lilla Nagy-Radványi
TKTamás Kőszegi
Tamás Kőszegi
RCRita Csepregi
Rita Csepregi
DNDávid U. Nagy
Dávid U. Nagy
Marianna KocsisMarianna Kocsis
Marianna Kocsis
Melissopalynology, antioxidant capacity and mineral and toxic element contents were analyzed in eight types of Hungarian honeys. Based on color, two groups were distinguished: light honeys comprised acacia, amorpha, phacelia and linden honeys; while dark honeys included sunflower, chestnut, fennel and sage honeys, with 100 to 300 and 700 to 1500 mAU, respectively. The unifloral origin of each sample was supported using pollen analysis. The absorbance of honey correlated positively with antioxidant capacity determined by three different methods (TRC, DPPH, ORAC), and also with mineral content. The exception was the light amber linden honey with significantly higher K content and antiradical activity than other light honeys. The Mn, Zn and Fe contents were the highest in chestnut, sunflower and fennel honeys, respectively. The black meadow sage honey performed best regarding the content of other elements and antioxidant activity. The concentrations of several toxic elements were below the detection limit in the samples, indicating their good quality. The principal component analysis (PCA) revealed correlations between different antioxidant assays and minerals, and furthermore, confirmed the botanical authentication of the honeys based on the studied parameters. To our best knowledge, the present study is the first to provide a complex analysis of quality parameters of eight unifloral Hungarian honeys.